跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 83,162 条关于
“STK11-mutated cancers”
全部
83,162
临床试验
71,608
药物
1,549
机构
286
资讯
9,719
去年
BerGenBio's AXL Inhibitor Receives FDA Fast Track for STK11-Mutated Cancers Amidst Leadership Transition
去年
NGS-Guided Treatment Strategy Shows Promise for STK11/KEAP1-Mutated NSCLC Patients
去年
BerGenBio's AXL Inhibitor Shows Promise in STK11-Mutated Lung Cancer, Faces Leadership Transition
2年前
Inavolisib Shows Promise in PIK3CA-Mutated Advanced Solid Tumors
去年
Panbela Therapeutics Initiates Phase I Trial of CPP-1X-S in STK11 Mutant NSCLC
2年前
Glecirasib Shows Promise in Pancreatic Cancer and Other Solid Tumors at ASCO GI 2024
2个月前
PARP Inhibitors Expand Beyond BRCA-Mutated Cancers: Emerging Evidence Across Solid Tumors and Combination Strategies
去年
Immunotherapy Strategies Evolving for NSCLC with KRAS and STK11 Mutations
去年
UCLA Researchers Receive $950,000 Grant to Launch Multi-Institutional Trial of Zipalertinib for EGFR-Mutated Cancers
2年前
Prelude Therapeutics' PRT3789 Shows Promise in SMARCA4-Mutated Cancers
第 1 页,共 972 页
上一页
下一页